104 results on '"Bruno, Cosimo Marcello"'
Search Results
2. Lifestyle and Hypertension: An Evidence-Based Review
3. Acid-base disturbance in liver cirrhosis
4. Gli squilibri idroelettrolitici e acido-base in medicina interna. 2° edizione
5. Necrotizing Panniculitis as an Uncommon Manifestation of Acute Pancreatitis
6. Comparison between bicarbonate-based and Stewart methods to assess metabolic acid-base disorders in internistic patients. A pilot study
7. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes
8. Tubular Handling of Uric Acid and Factors Influencing Its Renal Excretion: A Short Review
9. ON-TREATMENT HBsAg DECLINE IS ASSOCIATED WITH SUBSEQUENT HBsAg REDUCTION IN HBeAg NEGATIVE CHRONIC HEPATITIS B
10. INFLAMMATORY AND ANGIOGENIC FACTORS SERUM LEVELS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
11. Acid-Base Disorders in Patients with Chronic Obstructive Pulmonary Disease: A Pathophysiological Review
12. COMPLICATION AND HOSPITALISATION AFTER PERCUTANEOUS LIVER BIOPSY: A COHORT STUDY OF 12 YARS
13. Steatohepatites Influence The Cardiovascular And Diabetus Mellitul Risk Profile
14. Erythropoietin alpha 40.000 IU increases haemoglobin levels and improves sustain virological response in combination therapy with peg-interferon/ribavirin in chronic hepatitis C
15. Suboptimal Endogenous Erythropoietin Response In Chronic Hepatitis C Patients During Peg-Interferon And Ribavirin Treatment
16. Association Between Diabetes Mellitus, Hepatic Steatosis And Fibrosis In Chronic Hepatitis C Patients
17. THE COMPARATIVE STUDY OF TERLIPRESSIN AND ALBUMIN FOR TYPE-1 HEPATORENAL SYNDROME (HRS) IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL PERITONITIS (SBP) VS CIRRHOSIS ALONE
18. URSODEOXYCHOLIC ACID AND SIMVASTATIN IN PATIENTS WITHNONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME
19. Sustained Virological Response reduces insulin resistance in patients with genotype 1 Chronic Hepatitis C
20. Epoetin alpha improves the response to antiviral treatment in HCV-related chrinic hepatitis
21. Co-administration ezetimibe/simvastatin teraphy decrease the supersaturation in gallbladder bile and prevent cholesterol gallstones formation
22. TRIGLYCERIDE SERUM LEVELS WERE INDEPENDENTLY ASSOCIATED WITH SERUM AMINOTRANSFERASE LEVELS IN NONALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH OBESITY
23. POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
24. CO-ADMINISTRATION EZETIMIBE/SIMVASTATIN TERAPHY DECREASES THE SUPER-SATURATION IN GALLBLADDER BILE AND PREVENT CHOLESTEROL GALLSTONES FORMATION
25. VISCERAL ADIPOSE TISSUE AREA AS INDEPENDENT RISK FACTOR OF ELEVATED ALANINE AMINOTRANSFERASE SERUM LEVELS
26. Efficacy and safety of paroxetine for prevention of depressive symptoms induced by peginterferon alpha-2a and ribavirin in chronic hepatitis C. A double-blind, randomized,placebo controlled study
27. Visceral adipose tissue area as independent risk factor of elevated alanine aminotransferase
28. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndroe
29. Valutazione e possibile significato dei livelli plasmatici di interleukina-10 nell’epatite cronica da virus C
30. Rapid virological response is predictor of sustained virological response in patients with chronic hepatitis C treated with peginterferon alfa-2a plus ribavirin
31. Gli squilibri idroelettrolitici e acido-base in Medicina Interna
32. Identification of genotypes and detection of hepatitis B virus resistance mutations
33. La metalloproteinasi-2 è un marker indiretto di citonecrosi e fibrosi epatica nell’epatite cronica HCV-correlata
34. Il consumo di alcol in gravidanza aumenta il rischio di parto pretermine e aborto spontaneo
35. A therapeutic education and medical support program improves adherence to therapy with peg-interferon plus ribavirin therapy and increases sustained virological response in patients with chronic hepatitis C
36. Considerazioni epidemiologiche sull’attività di ricovero di una U.O.C. di Medicina Interna della Sicilia orientale
37. Livelli circolanti di interleuchina-10 in soggetti affetti da epatopatia cronica:studio pilota
38. Peg-interferon alfa 2a versus lamivudina nel trattamento dell'epatite cronica HBeAg negativa/HBeAb positiva. Studio pilota
39. Pegylated-interferon and ribavirin therapy of HCV-related type II mixed cryoglobulinemia
40. Ruolo di MMP-2 e MMP-9 come indicatori prognostici indiretti nella progressione delle epatopatie croniche
41. Peg-interferone alfa 2a versus lamivudina nel trattamento dell'epatite cronica HBeAg negativa/HBeAb positiva.Studio pilota
42. Infezione da HAV in pazienti con epatite cronica HCV correlata
43. Livelli circolanti di interleuchina-10 in soggetti affetti da epatopatia cronica: studio pilota
44. Infezione da HAV in pazienti con epatite cronica HCV-correlata
45. Ferro e ferrodeplezione nell'epatite cronica HCV-correlata
46. Una inusuale associazione:epatite autoimmune tipo I - ipertensione polmonare idiopatica
47. Ferro e ferrodeplezione nell'epatite cronica HCV-correlata.Studio pilota
48. Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers
49. Riduzione dell’incidenza di HCC in soggetti con cirrosi epatica HCV-correlata
50. Eritropoietina nel trattamento dell’anemia secondaria a terapia con interferone peghilato e ribavirina
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.